Zymocort Special Precautions

Mometasone furoate (Zymocort) Nasal Spray should be used with caution, if at all, in patients with active or quiescent tuberculous infections of the respiratory tract, or in untreated fungal bacterial, systemic viral infections or ocular herpes simplex.
Following 12 months of treatment with Mometasone furoate (Zymocort) Nasal Spray there was no evidence of atrophy of the nasal mucosa, also mometasone furoate tended to reverse the nasal mucosa closer to a normal histologic phenotype.
As with any long-term treatment, patients using Mometasone furoate (Zymocort) Nasal Spray over several months or longer should be examined periodically for possible changes in the nasal mucosa. If localized fungal infection of the nose or pharynx develops discontinuation of Mometasone furoate (Zymocort) Nasal Spray therapy or appropriate treatment may be required. Persistence of nasopharyngeal irritation may be an indication for discontinuing Mometasone furoate (Zymocort) Nasal Spray. Although Mometasone furoate (Zymocort) will control the nasal symptoms in most patients, the concomitant use of appropriate additional therapy may provide additional relief of other symptoms, particularly ocular symptoms.
Effect to drive and use the machine: None known.